78 research outputs found
Π‘ΠΊΡΠΈΠ½ΠΈΠ½Π³ ΠΊΠ°Π»ΡΡΠΈΠ½ΠΎΠ·Π° ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΡΡ Π°ΡΡΠ΅ΡΠΈΠΉ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΌΡΠ»ΡΡΠΈΡΠΏΠΈΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΊΠΎΠΌΠΏΡΡΡΠ΅ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ
Coronary atherosclerosis and coronary artery diseaseΒ (CAD) are theΒ most common causes of death and disability inΒ the most ofΒ industrialized countries. The problem of earlyΒ diagnosis of CADΒ detection is extremely relevant all over theΒ world. PreclinicalΒ identification of patients with risk factors ofΒ CAD is one of the mostΒ important goal in routine clinical practice.Β Multislice computedΒ tomography (MSCT) of the heartΒ with the determination of theΒ calcium index (CI) is a noninvasiveΒ screening of coronary arteriesΒ assessment. TheΒ severity of coronary calcification has a closeΒ relationship withΒ the severity of coronary atherosclerosis and the risk of acuteΒ coronary events according to numerous studies. Initially,Β studies targeted on assessment of coronary calcification andΒ determination of normative parameters were performedΒ using electron-beam scanners (EBS). Subsequently multisliceΒ computed tomography (MSCT) replaced the electronicΒ beam tomography (EBCT). The results of studies thatΒ performed with EBS have become the basis for a methodologyΒ of coronary calcification assessment with MSCT. TheΒ reproducibility of coronary calcium score is important for assessment of atherosclerosis for dynamic monitoring. The inter- observer and intra-observer reproducibility of this method is quiteΒ high, the reproducibility according to repeated studies of the sameΒ patient is lower. In recent years, a new generation of volumetric CT- scanners has been introduced into clinical practice. Reducing the radiation dose for coronary calcium screening to the minimum values (less than 1 mSv) is one of the important advantages of volumetricΒ computed tomography. Currently, new studies are needed to assessΒ the reproducibility of coronary calcium index calculation using a newΒ generation of volumetric CT-scanners.ΠΡΠ΅ΡΠΎΡΠΊΠ»Π΅ΡΠΎΠ· ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΡΡ
Π°ΡΡΠ΅ΡΠΈΠΉ ΠΈ ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠ°ΡΒ Π±ΠΎΠ»Π΅Π·Π½Ρ ΡΠ΅ΡΠ΄ΡΠ° (ΠΠΠ‘) ΡΠ²Π»ΡΡΡΡΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠΌΠΈ ΠΏΡΠΈΡΠΈΠ½Π°ΠΌΠΈ ΡΠΌΠ΅ΡΡΠΈ ΠΈ ΠΈΠ½Π²Π°Π»ΠΈΠ΄ΠΈΠ·Π°ΡΠΈΠΈ Π² Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π΅ ΠΈΠ½Π΄ΡΡΡΡΠΈΠ°Π»ΡΠ½ΠΎ ΡΠ°Π·Π²ΠΈΡΡΡ
ΡΡΡΠ°Π½ ΠΌΠΈΡΠ°. ΠΡΠΎΠ±Π»Π΅ΠΌΠ°Β ΡΠ°Π½Π½Π΅ΠΉ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΠΠ‘ ΠΊΡΠ°ΠΉΠ½Π΅ Π°ΠΊΡΡΠ°Π»ΡΠ½Π° Π²ΠΎ Π²ΡΠ΅ΠΌ ΠΌΠΈΡΠ΅. ΠΠΎΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°ΠΊΡΠΎΡΠ°ΠΌΠΈ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠΠ‘ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ·Β Π²Π°ΠΆΠ½Π΅ΠΉΡΠΈΡ
Π·Π°Π΄Π°Ρ Π² ΡΡΡΠΈΠ½Π½ΠΎΠΉ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅.Β ΠΠ΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΠΌ ΡΠΊΡΠΈΠ½ΠΈΠ½Π³ΠΎΠ²ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΒ ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΡΡ
Π°ΡΡΠ΅ΡΠΈΠΉ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΌΡΠ»ΡΡΠΈΡΠΏΠΈΡΠ°Π»ΡΠ½Π°Ρ ΠΊΠΎΠΌΠΏΡΡΡΠ΅ΡΠ½Π°Ρ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΡ (ΠΠ‘ΠΠ’) ΡΠ΅ΡΠ΄ΡΠ° Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ΠΌΒ ΠΊΠ°Π»ΡΡΠΈΠ΅Π²ΠΎΠ³ΠΎ ΠΈΠ½Π΄Π΅ΠΊΡΠ°. ΠΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΌΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΡ
Β ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΡ ΠΊΠ°Π»ΡΡΠΈΠ½ΠΎΠ·Π° ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΡΡ
Β Π°ΡΡΠ΅ΡΠΈΠΉ ΠΈΠΌΠ΅Π΅Ρ ΡΠ΅ΡΠ½ΡΡ ΡΠ²ΡΠ·Ρ Ρ ΡΡΠΆΠ΅ΡΡΡΡ Π°ΡΠ΅ΡΠΎΡΠΊΠ»Π΅ΡΠΎΠ·Π°Β ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΡΡ
Π°ΡΡΠ΅ΡΠΈΠΉ ΠΈ ΡΠΈΡΠΊΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΡΡ
Β ΡΠΎΠ±ΡΡΠΈΠΉ. ΠΠ΅ΡΠ²ΠΎΠ½Π°ΡΠ°Π»ΡΠ½ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎ ΠΎΡΠ΅Π½ΠΊΠ΅ ΠΊΠ°Π»ΡΡΠΈΠ½ΠΎΠ·Π° ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΡΡ
Π°ΡΡΠ΅ΡΠΈΠΉ ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π½ΠΎΡΠΌΠ°ΡΠΈΠ²Π½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π±ΡΠ»ΠΈ Π²ΡΠΏΠΎΠ»Π½Π΅Π½Ρ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌΒ ΡΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΠΎ-Π»ΡΡΠ΅Π²ΡΡ
ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΎΠ². ΠΠΎΠ·ΠΆΠ΅ ΠΠ‘ΠΠ’ Π·Π°ΠΌΠ΅Π½ΠΈΠ»Π° ΡΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΠΎ-Π»ΡΡΠ΅Π²ΡΡ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ, Π²ΡΠΏΠΎΠ»Π½Π΅Π½Π½ΡΡ
Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΠΎ- Π»ΡΡΠ΅Π²ΡΡ
Β ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΎΠ², ΡΡΠ°Π»ΠΈ ΠΎΡΠ½ΠΎΠ²ΠΎΠΉ Π΄Π»Ρ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΈΒ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΊΠ°Π»ΡΡΠΈΠ½ΠΎΠ·Π°Β ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΡΡ
Π°ΡΡΠ΅ΡΠΈΠΉ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΠ‘ΠΠ’. ΠΠΎΡΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΏΠΎΠ΄ΡΡΠ΅ΡΠ°Β ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΠΊΠ°Π»ΡΡΠΈΠ΅Π²ΠΎΠ³ΠΎ ΠΈΠ½Π΄Π΅ΠΊΡΠ° Π²Π°ΠΆΠ½Π° Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈΒ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π°ΡΠ΅ΡΠΎΡΠΊΠ»Π΅ΡΠΎΠ·Π°. ΠΡΠΈΒ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ ΠΠ‘ΠΠ’Β ΠΌΠ΅ΠΆΠΎΠΏΠ΅ΡΠ°ΡΠΎΡΡΠΊΠ°Ρ ΠΈ Π²Π½ΡΡΡΠΈΠΎΠΏΠ΅ΡΠ°ΡΠΎΡΡΠΊΠ°Ρ Π²ΠΎΡΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡΡΒ Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎ Π²ΡΡΠΎΠΊΠΈ, ΠΏΡΠΈ ΠΏΠΎΠ²ΡΠΎΡΠ½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΡ
Ρ ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΈ ΡΠΎΠ³ΠΎ ΠΆΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°Β Π²ΠΎΡΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡΡΒ ΠΌΠ΅ΡΠΎΠ΄Π° Π½ΠΈΠΆΠ΅. Π ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΠ΅ Π³ΠΎΠ΄Ρ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΡΡ ΠΏΡΠ°ΠΊΡΠΈΠΊΡΒ Π±ΡΠ»ΠΎ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΎΒ Π½ΠΎΠ²ΠΎΠ΅ ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΠ΅ ΡΠΈΡΠΎΠΊΠΎΠ΄Π΅ΡΠ΅ΠΊΡΠΎΡΠ½ΡΡ
Β ΠΎΠ±ΡΠ΅ΠΌΠ½ΡΡ
ΠΊΠΎΠΌΠΏΡΡΡΠ΅ΡΠ½ΡΡ
ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΎΠ². Π‘Π½ΠΈΠΆΠ΅Π½ΠΈΠ΅ Π»ΡΡΠ΅Π²ΠΎΠΉ Π½Π°Π³ΡΡΠ·ΠΊΠΈ Π΄ΠΎ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½ΡΡ
Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈΒ ΡΠΊΡΠΈΠ½ΠΈΠ½Π³Π° ΠΊΠ°Π»ΡΡΠΈΠ½ΠΎΠ·Π°Β ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΡΡ
Π°ΡΡΠ΅ΡΠΈΠΉ ΡΠ²Π»ΡΠ΅ΡΡΡΒ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· Π²Π°ΠΆΠ½ΡΡ
ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ² ΠΎΠ±ΡΠ΅ΠΌΠ½ΡΡ
ΠΊΠΎΠΌΠΏΡΡΡΠ΅ΡΠ½ΡΡ
Β ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΎΠ². Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎ ΠΎΡΠ΅Π½ΠΊΠ΅ Π²ΠΎΡΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈΒ ΠΏΠΎΠ΄ΡΡΠ΅ΡΠ° ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΠΊΠ°Π»ΡΡΠΈΠ΅Π²ΠΎΠ³ΠΎ ΠΈΠ½Π΄Π΅ΠΊΡΠ° ΠΏΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ Π½ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΡ ΠΊΠΎΠΌΠΏΡΡΡΠ΅ΡΠ½ΡΡ
ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΎΠ²
ΠΠ£Π§ΠΠΠΠ― ΠΠΠΠΠΠΠ‘Π’ΠΠΠ ΠΠΠ’ΠΠΠΠΠΠ ΠΠΠ’ΠΠΠΠΠ€ΠΠΠΠ ΠΠΠ¬ΠΠΠΠ Π‘ΠΠ§ΠΠΠΠΠΠΠ―
The problem of diagnosis and treatment of diseases of the patellofemoral joint (PFJ) remains relevant currently, since joint damage affects mainly young employable patients. The review analyzes the data of foreign and domestic literature on methods of the visualization of pathological conditions of patellofemoral articulation. Analysis of the literature has shown that now there is no single algorithm for detecting the pathology of PFJ by radiological methods, especially on early stages, when the effectiveness of treatment is the highest.Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΏΠ°ΡΠ΅Π»Π»ΠΎΡΠ΅ΠΌΠΎΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΡΠ»Π΅Π½Π΅Π½ΠΈΡ (ΠΠ€Π‘) ΡΠΎΡ
ΡΠ°Π½ΡΠ΅Ρ ΡΠ²ΠΎΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ ΡΡΡΡΠ°Π²Π° Π·Π°ΡΡΠ°Π³ΠΈΠ²Π°Π΅Ρ Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΌ ΠΌΠΎΠ»ΠΎΠ΄ΡΡ
ΡΡΡΠ΄ΠΎΡΠΏΠΎΡΠΎΠ±Π½ΡΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². Π ΠΎΠ±Π·ΠΎΡΠ΅ ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ Π΄Π°Π½Π½ΡΠ΅ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΠΎΠΉ ΠΈ ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ, ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π½ΡΠ΅ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌ Π»ΡΡΠ΅Π²ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΎΡΡΠΎΡΠ½ΠΈΠΉ ΠΠ€Π‘. ΠΠ½Π°Π»ΠΈΠ· Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ ΠΏΠΎΠΊΠ°Π·Π°Π», ΡΡΠΎ Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π½Π΅Ρ Π΅Π΄ΠΈΠ½ΠΎΠ³ΠΎ Π°Π»Π³ΠΎΡΠΈΡΠΌΠ° Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΠ€Π‘ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ Π»ΡΡΠ΅Π²ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ Π½Π° ΡΠ°Π½Π½ΠΈΡ
ΡΡΠ°Π΄ΠΈΡΡ
, ΠΊΠΎΠ³Π΄Π° ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠ°ΠΌΠ°Ρ Π²ΡΡΠΎΠΊΠ°Ρ
ΠΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π»ΡΡΠ΅Π²ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π² ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΈ ΠΏΡΠ΅Π΄ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΠ°ΡΠΊΡΠ°ΡΠΈΠΈ Π°ΠΎΡΡΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ ΠΌΠ»Π°Π΄ΡΠ΅ΠΉ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ
Objective. Evaluation of diagnostic value of modern imaging modalities: trans-thoracic echocardiography (TTE), CT-angiography (CTA) and cardio-MRI in diagnosis and preoperative planning of aortic coarctation correction (CoA) in in infants and young age group children.Materials and methods. 101 pediatric patients (aged 0 to 5 years) with CoA underwent TTE, 98 of them underwent CT, 30 β cardio MRI. On TTE, CTA and cardio-MRI aorta morphometry was performed. The most common anomalies associated with CoA (ventricular septal defect (VSD), patent ductus arteriosus (PDA), aberrant right subclavian artery (ARSA), hypoplastic arch and brachiocephalic vessels anomalies) were assessed.Results. The overall diagnostic accuracy of TTE, CT and cardiac-MRI in diagnosis of CoA were 89.1%, 95.9%, 86.7% respectively. There was no significant difference in the accuracy in detecting CoA between TTE, CT and MRI (p > 0.05). The accuracy of TTE in determining the brachiocephalic vessels anomalies, ARSA and arch hypoplasia was 84%, 93% and 85.3%, respectively. The accuracy of CT in determining the brachiocephalic vessels anomalies, ARSA and arch hypoplasia was 100%, 100% and 98% and cardio-MRI: 97.1%, 98.4% and 96.8%, respectively.Conclusion. TTE is a widely available and safe method, it has a high diagnostic value in determining CoA. Due to limitations in visualization of all parts of the aortic arch and the detection of concomitant anomalies, TTE cannot be the final method in planning the CoA correction. CT and MRI of the heart, as a TTE, are effective methods in the diagnosis of CoA, however, in the assessment of extracardiac anomalies, they equally show a significantly more accurate result.Taking into account the difficulties in conducting MRI of the heart in children under one year and younger age group, the need for a longer stay in anesthesia, the lack of additional diagnostically significant information in comparison with CT of the heart, cardio-MRI is not the method of choice in the primary diagnosis and preoperative planning of correction of CoA in children under one year and younger age group requiring the use of an anesthetic aid for the duration of the scan. Cardio-MRI may be the method of choice in preoperative planning of CoA in small children with absolute contraindications to the radiocontrast agent.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ: ΠΎΡΠ΅Π½ΠΈΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ: ΠΡ
ΠΎΠΠ, ΠΠ’ ΠΈ ΠΠ Π’ ΡΠ΅ΡΠ΄ΡΠ° Π² Π²ΡΡΠ²Π»Π΅Π½ΠΈΠΈ ΠΈ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ ΠΊΠΎΠ°ΡΠΊΡΠ°ΡΠΈΠΈ Π°ΠΎΡΡΡ (ΠΠΎΠΠΎ) Ρ Π΄Π΅ΡΠ΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ ΠΌΠ»Π°Π΄ΡΠ΅ΠΉ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠ΅Π½ 101 ΡΠ΅Π±Π΅Π½ΠΎΠΊ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 0 Π΄ΠΎ 5 Π»Π΅Ρ. ΠΡΠ΅ΠΌ Π΄Π΅ΡΡΠΌ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΡ
ΠΎΠΠ, 98 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ β ΠΠ’ ΡΠ΅ΡΠ΄ΡΠ°, 30 β ΠΠ Π’ ΡΠ΅ΡΠ΄ΡΠ°. ΠΡΠΈ ΠΈΠ½ΡΠ΅ΡΠΏΡΠ΅ΡΠ°ΡΠΈΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΡ
ΠΎΠΠ, ΠΠ’ ΠΈ ΠΠ Π’ ΡΠ΅ΡΠ΄ΡΠ° ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ»ΠΈΡΡ Π°Π½Π°Π»ΠΈΠ· ΠΈ ΠΌΠΎΡΡΠΎΠΌΠ΅ΡΡΠΈΡ Π²ΡΠ΅Ρ
ΠΎΡΠ΄Π΅Π»ΠΎΠ² Π°ΠΎΡΡΡ, ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ ΠΎΡΠ΅Π½ΠΊΠ° Π½Π°Π»ΠΈΡΠΈΡ ΡΠΎΠΏΡΡΡΡΠ²ΡΡΡΠΈΡ
Π°Π½ΠΎΠΌΠ°Π»ΠΈΠΉ: Π°Π±Π΅ΡΡΠ°Π½ΡΠ½Π°Ρ ΠΏΡΠ°Π²Π°Ρ ΠΏΠΎΠ΄ΠΊΠ»ΡΡΠΈΡΠ½Π°Ρ Π°ΡΡΠ΅ΡΠΈΡ, ΡΠ΅ΠΏΡΠ°Π»ΡΠ½ΡΠ΅ Π΄Π΅ΡΠ΅ΠΊΡΡ, ΠΎΡΠΊΡΡΡΡΠΉ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΠΉ ΠΏΡΠΎΡΠΎΠΊ, ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ Π±ΡΠ°Ρ
ΠΈΠΎΡΠ΅ΡΠ°Π»ΡΠ½ΡΡ
ΡΠΎΡΡΠ΄ΠΎΠ² (ΠΠ¦Π‘) ΠΈ ΡΠΎΠΏΡΡΡΡΠ²ΡΡΡΠ°Ρ Π³ΠΈΠΏΠΎΠΏΠ»Π°Π·ΠΈΡ Π΄ΡΠ³ΠΈ Π°ΠΎΡΡΡ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠΎΡΠ½ΠΎΡΡΡ ΠΡ
ΠΎΠΠ, ΠΠ’ ΠΈ ΠΠ Π’ ΡΠ΅ΡΠ΄ΡΠ° Π² ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΠΎΠΠΎ Ρ Π΄Π΅ΡΠ΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ ΠΌΠ»Π°Π΄ΡΠ΅ΠΉ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 89,1, 95,9, 86,7% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ. Π ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΠ¦Π‘, Π°Π±Π΅ΡΡΠ°Π½ΡΠ½ΠΎΠΉ ΠΏΡΠ°Π²ΠΎΠΉ ΠΏΠΎΠ΄ΠΊΠ»ΡΡΠΈΡΠ½ΠΎΠΉ Π°ΡΡΠ΅ΡΠΈΠΈ ΠΈ Π³ΠΈΠΏΠΎΠΏΠ»Π°Π·ΠΈΠΈ Π΄ΡΠ³ΠΈ ΡΠΎΡΠ½ΠΎΡΡΡ ΠΡ
ΠΎΠΠ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 84, 93 ΠΈ 85,3% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ. ΠΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠ²Π½ΠΎΡΡΡ ΠΠ’ Π² ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΠ¦Π‘, Π°Π±Π΅ΡΡΠ°Π½ΡΠ½ΠΎΠΉ ΠΏΡΠ°Π²ΠΎΠΉ ΠΏΠΎΠ΄ΠΊΠ»ΡΡΠΈΡΠ½ΠΎΠΉ Π°ΡΡΠ΅ΡΠΈΠΈ ΠΈ Π³ΠΈΠΏΠΎΠΏΠ»Π°Π·ΠΈΠΈ Π΄ΡΠ³ΠΈ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 100, 100 ΠΈ 98% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ. Π’ΠΎΡΠ½ΠΎΡΡΡ ΠΊΠ°ΡΠ΄ΠΈΠΎ-ΠΠ Π’ Π² ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΠ¦Π‘, Π°Π±Π΅ΡΡΠ°Π½ΡΠ½ΠΎΠΉ ΠΏΡΠ°Π²ΠΎΠΉ ΠΏΠΎΠ΄ΠΊΠ»ΡΡΠΈΡΠ½ΠΎΠΉ Π°ΡΡΠ΅ΡΠΈΠΈ ΠΈ Π³ΠΈΠΏΠΎΠΏΠ»Π°Π·ΠΈΠΈ Π΄ΡΠ³ΠΈ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 97,1, 98,4 ΠΈ 96,8% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡ
ΠΎΠΠ, Π±ΡΠ΄ΡΡΠΈ ΡΠΈΡΠΎΠΊΠΎΠ΄ΠΎΡΡΡΠΏΠ½ΡΠΌ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ, ΠΈΠΌΠ΅Π΅Ρ Π²ΡΡΠΎΠΊΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΡΡ ΡΠ΅Π½Π½ΠΎΡΡΡ Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΠΠΎΠΠΎ, ΠΎΠ΄Π½Π°ΠΊΠΎ Π²Π²ΠΈΠ΄Ρ ΠΎΠ³ΡΠ°Π½ΠΈΡΠ΅Π½ΠΈΠΉ Π² Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ Π²ΡΠ΅Ρ
ΠΎΡΠ΄Π΅Π»ΠΎΠ² Π΄ΡΠ³ΠΈ Π°ΠΎΡΡΡ ΠΈ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΡΠΎΠΏΡΡΡΡΠ²ΡΡΡΠΈΡ
ΡΠΊΡΡΡΠ°ΠΊΠ°ΡΠ΄ΠΈΠ°Π»ΡΠ½ΡΡ
Π°Π½ΠΎΠΌΠ°Π»ΠΈΠΉ Π½Π΅ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΎΠΊΠΎΠ½ΡΠ°ΡΠ΅Π»ΡΠ½ΡΠΌ ΠΏΡΠΈ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ ΠΠΎΠΠΎ Ρ ΠΌΠ°Π»Π΅Π½ΡΠΊΠΈΡ
Π΄Π΅ΡΠ΅ΠΉ. ΠΠ’ ΠΈ ΠΠ Π’ ΡΠ΅ΡΠ΄ΡΠ° Π½Π°ΡΠ°Π²Π½Π΅ Ρ ΠΡ
ΠΎΠΠ ΡΠ²Π»ΡΡΡΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠ°ΠΌΠΈ Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ Π»ΠΎΠΊΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΠΆΠ΅Π½ΠΈΡ Π°ΠΎΡΡΡ, ΠΎΠ΄Π½Π°ΠΊΠΎ Π² ΠΎΡΠ΅Π½ΠΊΠ΅ ΡΠΊΡΡΡΠ°ΠΊΠ°ΡΠ΄ΠΈΠ°Π»ΡΠ½ΡΡ
Π°Π½ΠΎΠΌΠ°Π»ΠΈΠΉ ΠΎΠ΄ΠΈΠ½Π°ΠΊΠΎΠ²ΠΎ ΠΏΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π±ΠΎΠ»Π΅Π΅ ΡΠΎΡΠ½ΡΠΉ ΡΠ΅Π·ΡΠ»ΡΡΠ°Ρ.ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΠ Π’ ΡΠ΅ΡΠ΄ΡΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ ΠΌΠ»Π°Π΄ΡΠ΅ΠΉ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΡΠΎΠΏΡΡΠΆΠ΅Π½ΠΎ Ρ ΡΠ΅Ρ
Π½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΡΠΌΠΈ ΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡΡ Π±ΠΎΠ»Π΅Π΅ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΡ Π² Π½Π°ΡΠΊΠΎΠ·Π΅. Π£ΡΠΈΡΡΠ²Π°Ρ ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠΉ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΈ Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠΈ Ρ ΠΠ’ ΡΠ΅ΡΠ΄ΡΠ°, ΠΊΠ°ΡΠ΄ΠΈΠΎ-ΠΠ Π’ Π½Π΅ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π²ΡΠ±ΠΎΡΠ° Π² ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΠΈ ΠΏΡΠ΅Π΄ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ ΠΠΎΠΠΎ Ρ Π΄Π΅ΡΠ΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ ΠΌΠ»Π°Π΄ΡΠ΅ΠΉ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ, ΡΡΠ΅Π±ΡΡΡΠΈΡ
ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π°Π½Π΅ΡΡΠ΅Π·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠΎΡΠΎΠ±ΠΈΡ Π½Π° Π²ΡΠ΅ΠΌΡ ΡΠΊΠ°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ
ΠΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½Π°Ρ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΡ Ρ ΠΎΡΡΡΠΎΡΠ΅Π½Π½ΡΠΌ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΡΠΈ ΡΠΈΠ±ΡΠΈΠ»Π»ΡΡΠΈΠΈ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ: ΠΏΠ΅ΡΠ²ΡΠ΅ Π΄ΠΎΡΡΠΈΠΆΠ΅Π½ΠΈΡ ΠΈ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ
Current paper reviews new opportunities in none invasiveΒ evaluationΒ of the left atrial fibrosis in atrial fibrillation usingΒ late gadoliniumΒ enhancement magnetic resonance imaging.Β The first use of thisΒ technology in clinical practice is discussed.Β In a group of prospectiveΒ studies it has been shown thatΒ structural atrial remodeling canΒ influence the clinical courseΒ of atrial fibrillation and the efficiency ofΒ arrhythmia treatment.Β Several groups of national and EuropeanΒ experts in morphologyΒ and MRI studies in a consensus suggestΒ introductionΒ of a new term fibrous atrial cardiomyopathy or fibrousΒ cardiomyopathy of atrii, representing the structural and functional pathology of atrii, of clinical value in atrial fibrillation. These dataΒ make evidence for possibly wide noninvasive MRI studies ofΒ cardiovascular out-patients in order to make obvious the structure of atrial myocardium and atrial anatomy as a whole. Progress in MRI technologies of heart studies provides the possibility of imaging ofΒ thin atrial myocardium both in patients with primarily documentedΒ atrial fibrillation and in persons after interventional treatment of the arrhythmia. There are reasons to expect that LGE MRI dataΒ regarding atrial structure in atrial fibrillation are in a position toΒ provide in a nearest future the improvement of management of such patients.Π ΡΡΠ°ΡΡΠ΅ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΉΒ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠΈΠ±ΡΠΎΠ·Π° Π»Π΅Π²ΠΎΠ³ΠΎ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΡ ΠΏΡΠΈΒ ΡΠΈΠ±ΡΠΈΠ»Π»ΡΡΠΈΠΈΒ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ ΠΏΡΠΈ ΠΏΠΎΠΌΠΎΡΠΈ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ (ΠΠ Π’) ΡΒ ΠΎΡΡΡΠΎΡΠ΅Π½Π½ΡΠΌ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΈ ΠΏΠ΅ΡΠ²ΡΠΉ ΠΎΠΏΡΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΡΠΎΠΉ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉΒ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅.Β Π ΡΡΠ΄Π΅ ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎΒ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΡΒ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄Π½ΠΎΠ³ΠΎ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π°Β ΠΌΠΎΠΆΠ΅Ρ Π²Π»ΠΈΡΡΡ Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π°ΡΠΈΡΠΌΠΈΠΈ ΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ Π΅Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ. Π ΡΠ΄ ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΈ Π΅Π²ΡΠΎΠΏΠ΅ΠΉΡΠΊΠΈΡ
ΡΠΊΡΠΏΠ΅ΡΡΠΎΠ²-ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΎΠ² ΠΈΒ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΎΠ² ΠΠ Π’ Π² ΡΠΎΠ²ΠΌΠ΅ΡΡΠ½ΠΎΠΌΒ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΡΠ΅ ΠΏΡΠ΅Π΄Π»Π°Π³Π°ΡΡ Π²Π²Π΅ΡΡΠΈ ΡΠ΅ΡΠΌΠΈΠ½ βΡΠΈΠ±ΡΠΎΠ·Π½Π°ΡΒ ΠΊΠ°ΡΠ΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°ΡΠΈΡ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉβ, ΠΎΡΡΠ°ΠΆΠ°ΡΡΠΈΠΉ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡΒ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ, ΠΈΠΌΠ΅ΡΡΡΡΒ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΡΡ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΡ ΠΏΡΠΈ ΡΠΈΠ±ΡΠΈΠ»Π»ΡΡΠΈΠΈ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ.Β ΠΡΠΈ Π΄Π°Π½Π½ΡΠ΅ ΠΎΠ±ΠΎΡΠ½ΠΎΠ²ΡΠ²Π°ΡΡ ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΡ Π² Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΌ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ ΡΠΈΡΠΎΠΊΠΎΠ³ΠΎ ΠΊΡΡΠ³Π°Β ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ΅Π»ΡΡ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΡΡΠΊΡΡΡΡ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄Π½ΠΎΠ³ΠΎΒ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π°.Β Π‘ΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΠ Π’ ΡΠ΅ΡΠ΄ΡΠ° Ρ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌΒ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°ΡΡ ΡΠΎΠ½ΠΊΠΈΠΉΒ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄Π½ΡΠΉ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄ ΠΊΠ°ΠΊ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π²ΡΡΠ²Π»Π΅Π½Π½ΠΎΠΉ ΠΌΠ΅ΡΡΠ°ΡΠ΅Π»ΡΠ½ΠΎΠΉ Π°ΡΠΈΡΠΌΠΈΠ΅ΠΉ, ΡΠ°ΠΊ ΠΈ Ρ Π»ΠΈΡ, ΠΏΠ΅ΡΠ΅Π½Π΅ΡΡΠΈΡ
ΠΈΠ½ΡΠ΅ΡΠ²Π΅Π½ΡΠΈΠΎΠ½Π½ΡΠ΅ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π°.Β Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π΅ΡΡΡ Π²ΡΠ΅ ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠ»Π°Π³Π°ΡΡ, ΡΡΠΎΒ ΠΠ Π’-Π΄Π°Π½Π½ΡΠ΅ ΠΎΒ ΡΡΡΡΠΊΡΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ ΠΏΡΠΈ ΡΠΈΠ±ΡΠΈΠ»Π»ΡΡΠΈΠΈΒ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ Π² Π±Π»ΠΈΠΆΠ°ΠΉΡΠ΅ΠΉ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π΅ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠ°ΡΒ ΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ°ΠΊΡΠΈΠΊΠΈ Π²Π΅Π΄Π΅Π½ΠΈΡ ΡΠ°ΠΊΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²
Methodology for knowledge portals development: background, foundations, experience of application, problems and prospects
The paper discusses an experience of using the methodology for the development of knowledge portals which provide systematization and integration of scientific and engineering knowledge and information resources as well as the content-based access to them. To provide a sufficiently complete and consistent representation of knowledge and information resources, their systematization and integration are performed on the basis of ontology. The suggested methodology has been successfully applied to the development of knowledge Internet portals on archaeology, computational linguistics, strength of materials and Antarctic data
ΠΠΠ ΠΠΠΠΠΠΠΠ Π‘ΠΠΠΠ ΠΠΠΠΠ― ΠΠΠ Π Π ΠΠΠ§ΠΠΠ Π£ ΠΠΠ¦ΠΠΠΠ’ΠΠ Π‘ ΠΠΠ ΠΠΠ«Π ΠΠΠΠΠ’ΠΠΠΠ Π Π‘Π’ΠΠΠ’ΠΠΠΠΠΠ’ΠΠ’ΠΠ ΠΠΠ’ΠΠΠΠ ΠΠ ΠΠ’ΠΠΠΠΠ ΠΠ -Π‘ΠΠΠΠ’Π ΠΠ‘ΠΠΠΠΠ
Aim. Evaluation of proton MR spectroscopy in the diagnostics of non-alcoholic fatty liver disease.Materials and methods. 70 patients (40 men, 30 women) with non-alcoholic fatty liver disease were included in the study. Average age of patients was 42 Β± 11 years. All patients were divided in two groups. The first group included patients with liver steΠ°thosis (n = 37). Patients with steatohepatitis detected by clinical data formed the second group (n = 33). All patients underwent MR spectroscopy for liver fat content evaluation in two time points (prescreening and after 6 months treatment).Results. MR spectroscopy showed fat content in patients with liver steatosis in the range from 7.5% to 58.4%, the median was 22.4% (lower and upper quartiles were 14.9% and 28.7%). After 6 months the liver fat content significantly decreased up to 1.5β43.7%, the median was 13.5% (the lower and upper quartiles were 5.54% and 18.9%). In patients with steatohepatitis the fat content calculated by MR spectroscopy ranged from 10.5% to 60%, the median was 28.8% (the lower and upper quartiles were 16.5% and 31.2%). There was no significant difference in fat content in this group after 6 months therapy (the median was 26.7%, the lower and upper quartiles were 14.2% and 28.7%, p = 0.22).Conclusion. Proton MR spectroscopy can be successfully used in patients with non-alcoholic fatty liver disease for liver fat content quantification in steatosis and steatohepatitis. MR spectroscopy can be discussed as a non-invasive biopsy alternative for dynamic evaluation during treatment.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ: ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΡΠΎΠ½Π½ΠΎΠΉ ΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΠΈ Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ Π½Π΅Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ ΠΆΠΈΡΠΎΠ²ΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΈ(ΠΠΠΠΠ).ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΎ Π²ΠΊΠ»ΡΡΠ΅Π½ΠΎ 70 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (40 ΠΌΡΠΆΡΠΈΠ½, 30 ΠΆΠ΅Π½ΡΠΈΠ½) Ρ ΠΠΠΠΠ, ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ ΠΊΠΎΡΠΎΡΡΡ
ΡΠΎΡΡΠ°Π²ΠΈΠ» 42 Β± 11 Π»Π΅Ρ. ΠΠ°ΡΠΈΠ΅Π½ΡΡ Π±ΡΠ»ΠΈ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° 2 Π³ΡΡΠΏΠΏΡ. 1-Ρ Π³ΡΡΠΏΠΏΠ° Π²ΠΊΠ»ΡΡΠ°Π»Π° Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠΎ ΡΡΠ΅Π°ΡΠΎΠ·ΠΎΠΌ ΠΏΠ΅ΡΠ΅Π½ΠΈ (37 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ). ΠΠΎ 2-Ρ Π³ΡΡΠΏΠΏΡ ΠΎΡΠ±ΠΈΡΠ°Π»ΠΈΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ ΡΠΎ ΡΡΠ΅Π°ΡΠΎΠ³Π΅ΠΏΠ°ΡΠΈΡΠΎΠΌ, Π²ΡΡΠ²Π»Π΅Π½Π½ΡΠΌ ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ (33 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°). ΠΡΠ΅ΠΌ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ Π²ΡΠΏΠΎΠ»Π½ΡΠ»Π°ΡΡ ΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΡ Π΄Π»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΠΆΠΈΡΠ° Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ Π² Π΄Π²ΡΡ
ΡΠΎΡΠΊΠ°Ρ
: ΠΏΠ΅ΡΠ΅Π΄ Π²ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ΠΌ Π² ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈ ΡΠΏΡΡΡΡ 6 ΠΌΠ΅Ρ Π½Π° ΡΠΎΠ½Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π 1-ΠΉ Π³ΡΡΠΏΠΏΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠΎ ΡΡΠ΅Π°ΡΠΎΠ·ΠΎΠΌ ΠΏΠ΅ΡΠ΅Π½ΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΆΠΈΡΠ° ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΠΈ Π½Π°Ρ
ΠΎΠ΄ΠΈΠ»ΠΎΡΡ Π² ΠΏΡΠ΅Π΄Π΅Π»Π°Ρ
ΠΎΡ 7,5 Π΄ΠΎ 58,4%, ΠΌΠ΅Π΄ΠΈΠ°Π½Π° ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 22,4%, Π½ΠΈΠΆΠ½ΡΡ ΠΈ Π²Π΅ΡΡ
Π½ΡΡ ΠΊΠ²Π°ΡΡΠΈΠ»ΠΈ β 14,9 ΠΈ 28,7%. ΠΡΠΈ ΡΠ΅Π³ΠΈΡΡΡΠ°ΡΠΈΠΈ ΡΠΏΠ΅ΠΊΡΡΠΎΠ² ΡΠΏΡΡΡΡ 6 ΠΌΠ΅Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΠΆΠΈΡΠ° Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ Π·Π½Π°ΡΠΈΠΌΠΎ ΡΠ½ΠΈΠ·ΠΈΠ»Π°ΡΡ, ΡΠΎΡΡΠ°Π²Π»ΡΠ»Π° ΠΎΡ 1,5 Π΄ΠΎ 43,7%, ΠΌΠ΅Π΄ΠΈΠ°Π½Π° β 13,5%, Π½ΠΈΠΆΠ½ΡΡ ΠΈ Π²Π΅ΡΡ
Π½ΡΡ ΠΊΠ²Π°ΡΡΠΈΠ»ΠΈ β 5,54 ΠΈ 18,9% (Ρ = 0,015). ΠΠΎ 2-ΠΉ Π³ΡΡΠΏΠΏΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠΎ ΡΡΠ΅Π°ΡΠΎΠ³Π΅ΠΏΠ°ΡΠΈΡΠΎΠΌ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΆΠΈΡΠ° ΠΏΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΠΈ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΎ ΠΎΡ 10,5 Π΄ΠΎ 60%, ΠΌΠ΅Π΄ΠΈΠ°Π½Π° β 28,8%, Π½ΠΈΠΆΠ½ΡΡ ΠΈ Π²Π΅ΡΡ
Π½ΡΡ ΠΊΠ²Π°ΡΡΠΈΠ»ΠΈ β 16,5 ΠΈ 31,2%. ΠΡΠΈ ΠΏΠΎΠ²ΡΠΎΡΠ½ΠΎΠΌ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ ΡΠ΅ΡΠ΅Π· 6 ΠΌΠ΅Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΆΠΈΡΠ° Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠΎ ΡΡΠ΅Π°ΡΠΎΠ³Π΅ΠΏΠ°ΡΠΈΡΠΎΠΌ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π½Π΅ ΠΈΠ·ΠΌΠ΅Π½ΠΈΠ»ΠΎΡΡ: ΠΌΠ΅Π΄ΠΈΠ°Π½Π° 26,7%, Π½ΠΈΠΆΠ½ΡΡ ΠΈ Π²Π΅ΡΡ
Π½ΡΡ ΠΊΠ²Π°ΡΡΠΈΠ»ΠΈ 14,2 ΠΈ 28,7%(Ρ = 0,22).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΎΡΠΎΠ½Π½Π°Ρ ΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΡ ΠΌΠΎΠΆΠ΅Ρ ΡΡΠΏΠ΅ΡΠ½ΠΎ ΠΏΡΠΈΠΌΠ΅Π½ΡΡΡΡΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΠΠΠΠ Π΄Π»Ρ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΠΆΠΈΡΠ° Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΏΡΠΈ ΡΡΠ΅Π°ΡΠΎΠ·Π΅ ΠΈ ΡΡΠ΅Π°ΡΠΎΠ³Π΅ΠΏΠ°ΡΠΈΡΠ΅. ΠΠ»Π°Π³ΠΎΠ΄Π°ΡΡ ΡΠ²ΠΎΠ΅ΠΉ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΡΡΠΈ ΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΡ ΠΌΠΎΠΆΠ΅Ρ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡΡΡ ΠΊΠ°ΠΊ Π°Π»ΡΡΠ΅ΡΠ½Π°ΡΠΈΠ²Π° Π±ΠΈΠΎΠΏΡΠΈΠΈ ΠΏΡΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ ΠΏΠΎΠ²ΡΠΎΡΠ½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π½Π° ΡΠΎΠ½Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ
Ultrasound examination with contrast in the diagnosis of inflammatory bowel disease. The results of the pilot study
Aim. Assessment of diagnostic significance of informativeness and security of ultrasonography with contrast enhancement drug SonoVue in the diagnosis of Crohn's disease (CD) and ulcerative colitis (UC). Materials and methods. The pilot conducted a prospective study which involved 15 patients with inflammatory bowel disease (IBD). All patients gave written consent to participate in the study and processing of personal data. The study included adult patients with an established diagnosis of UC and CD, with proven clinical activity of the disease. Activity was evaluated based on clinical and laboratory data on the scale of best (CDAI >150) for patients with CD and on a scale of Trulove-Witts (2-3 stage) and the Mayo index (DAI) for patients with UC. All the patients underwent colonoscopy with biopsy, ultrasound examination of abdominal cavity organs with the study of the vascularization of the intestinal wall (color Doppler, power Doppler, contrast study). Results. The use of contrast showed additional features in the instrumental evaluation of activity of inflammatory process, identification of complications and assessment of prognosis. Conclusion. The results of ultrasound of the bowel with contrast can be used to assess the activity and stage of disease in patients with UC or CD
Sequelae of COVID-19 at long-term follow-up after hospitalization
Aim. To assess long-term sequelae of COVID-19 in hospitalized patients at 3 to 7 months after discharge.Material and Methods. The whole of 700 patients hospitalized to the temporary COVID-19 treatment center hosted by the FSBI βNational Medical Research Center of Cardiologyβ of the Ministry of Health of Russia from April to June 2020 were invited to participate in a follow-up study. At 3-7 months after the index hospitalization, patients or their proxies were contacted via telephone in order to obtain information on their vital status, cardiovascular and other conditions or their complications, and new hospitalizations. In addition, patients were invited to an outpatient visit under the "COVID-19-follow-up" program, encompassing physical examination and a comprehensive battery of laboratory and instrumental tests, including spirometry, chest computed tomography (CT) and the six minute walk test (6MWT). Further, dyspnea was assessed using the mMRC (Modified Medical Research Council) Dyspnea Scale.Β Results: We were able to contact 87.4% (612/700) of patients or their proxies. At follow-up, 4.4% (27) patients died, of which 96.3% (26) had cardiovascular diseases (CVD). A total of 213 patients aged 19 to 94 years old (mean age 56.8Β±12.5, median 57 years [49.0; 64.0]; men, 55.4%) agreed come for an outpatient visit and to participate in the βCOVID-19-follow-upβ program. Since discharge, 8% (17) of patients required new hospitalizations, and more than a half of these patients (58.8%; 10/17) had CVD-related hospitalizations. A total of 8.4% (18) patients experienced worsening of hypertension, 9 (4.2%) patients had newly diagnosed hypertension, 2 (0.9%) β coronary artery disease patients experienced new/recurrent angina symptoms. 4 (1.9%) patients had newly diagnosed coronary artery disease, and one patient had an ischemic stroke. At the outpatient visit, 114 (53.5%) patients had some symptoms, most frequently, shortness of breath (33%), fatigue (27.4%), chest pain (11.3%), and abnormal heartbeats (8.5%). Based on the mMRC Scale, 59% of patients had dyspnea of varying severity. Most patients had a normal vital capacity (VC), which was moderately reduced in 3.3% and severely reduced in 0.5% of patients. Chest CT scans were obtained in 78 (36.6%) patients, whose worst lung damage scores during hospitalization were CT3 or CT4. One in ten patients (10.8%) with severe lung damage during acute infection had persisting ground glass opacities, 35.9% developed fibrotic changes, 79.6% of patients had linear or fine focal opacities. According to the 6MWT data, 12.3% of patients walked less than 70% of the predicted distance, 67% walked 71 to 99% of the predicted distance, and 20.7% of patients were able to walk 100% of their predicted distance.Conclusion. These data suggest long-term negative sequelae of COVID-19 in more than half of hospitalized patients
Prerequisites for the creation of an atlas of postcovid inflammation as a way of personalized pharmacotherapy, as well as predicting and preventing organ and systemic dysfunctions
SARS-CoV-2 is a novel coronavirus that has been identified as the cause of the 2019 coronavirus infection (COVID-19), which originated at Wuhan city of PRC in late 2019 and widespread worldwide. As the number of patients recovering from COVID-19 continue to grow, itβs very important to understand what health issues they may keep experiencing. COVID-19 is now recognized as an infectious disease that can cause multiple organ diseases of various localization. It is against this background that a new term was introduced: post-acute post-COVID-19 syndrome characterized by several persistent symptoms inherent in the acute phase of the disease, as well as the occurrence of delayed and (or) long-term complications beyond 4 weeks from the onset of the disease. The work reflected in this article revealed a portrait of a patient with post-COVID-19 syndrome, the most common complications of this period, as well as the mechanisms of their development and the resulting metabolic, cellular, tissue disorders leading to the tissue and organ dysfunctions. A comprehensive biochemical and immunological screening was carried out using the example of three clinical cases to identify the most significant disorders in these patients and to correlate with their clinical status over time. In point of fact, such patients were diagnosed with vascular dysfunction factors (development of endothelial dysfunction), metabolic dysfunction factors (metabolic acidosis, mitochondrial dysfunction, carbohydrate metabolism disorder, insulin resistance, altered branched-chain and aromatic amino acid metabolism), neurological disorder factors (neurotoxicity of the resulting metabolites), immunological disorder factors (decreased efficiency of detoxification systems, secondary immunodeficiency, risk of secondary bacterial infection)
ΠΠ°ΡΡΡΠ΅Π½ΠΈΡ ΡΠΈΠ½Ρ ΡΠΎΠ½ΠΈΠ·Π°ΡΠΈΠΈ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ ΠΈ Π΄ΡΡ Π°Π½ΠΈΡ ΠΏΡΠΈ Π³ΠΈΠΏΠ΅ΡΠΊΠ°ΠΏΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄ΡΡ Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ±Π΅ ΠΈ ΡΠΌΠ΅ΡΠ΅Π½Π½ΡΡ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΈΡ Π½Π°Π³ΡΡΠ·ΠΊΠ°Ρ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² c ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ
Relevance.The comprehensive assessment of cardiorespiratory coupling (CRC) for the diagnosis of functional adaptation in pulmonological patients is presented.The objective of the study was to test the complex criteria of CRC for objective differential diagnosis of individual adaptive reactions of pulmonological patients.Methods and materials. 30 volunteers without verified pathology and 31 patients with restrictive and obstructive disorders were examined. All subjects underwent physical examination with traditional routine method using spiroarteriocardiorhythmography (SACR) at rest and during performing functional tests with hypercapnia and moderate physical exercise.Results. We proposed the methodology of integrated assessment of multicomponent system of CRC, which increases the diagnostic precision of SACR in the tasks of predicting the adaptive defects of the organism at different pulmonary syndromes.Conclusion. Breathing with a fixed frequency normalizes the regulation of CRC, both in healthy and pulmonological patients. Moderate physical activity (80 W) modifies the indicators of CRC in pulmonological patients in comparison with the control group statistically due to disorders of the heart rate and circulation. During moderate physical activity, stroke volume (SV) statistically decreases in patients differently: SV were significantly lower in the group with obstructive disorders than in the group with non-obstructive disorders.Β ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. ΠΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π° ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½Π°Ρ ΠΎΡΠ΅Π½ΠΊΠ° ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΠΎ-Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΈΠ½Ρ
ΡΠΎΠ½ΠΈΠ·Π°ΡΠΈΠΈ (Π‘Π‘ΠΠ‘) Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β Π°ΠΏΡΠΎΠ±Π°ΡΠΈΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΡΡ
ΠΊΡΠΈΡΠ΅ΡΠΈΠ΅Π² Π‘Π‘ΠΠ‘ Π΄Π»Ρ ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΡ
ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΡΠ΅Π°ΠΊΡΠΈΠΉ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ.ΠΠ΅ΡΠΎΠ΄Ρ ΠΈ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ 30 Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»ΡΡΠ΅Π² Π±Π΅Π· Π²Π΅ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ 31 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° Ρ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΠΌΠΈ ΠΈ Π½Π΅ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΠΌΠΈ Π½Π°ΡΡΡΠ΅Π½ΠΈΡΠΌΠΈ. ΠΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΡΠΈΠ·ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠ΅ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠΎ ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΡΡΠΈΠ½Π½ΠΎΠΉ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠ΅ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠΏΠΈΡΠΎΠ°ΡΡΠ΅ΡΠΈΠΎΠΊΠ°ΡΠ΄ΠΈΠΎΡΠΈΡΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ (Π‘ΠΠΠ ) Π² ΠΏΠΎΠΊΠΎΠ΅ ΠΈ ΠΏΡΠΈ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΠΏΡΠΎΠ± Ρ Π³ΠΈΠΏΠ΅ΡΠΊΠ°ΠΏΠ½ΠΈΠ΅ΠΉ ΠΈ ΡΠΌΠ΅ΡΠ΅Π½Π½ΠΎΠΉ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π½Π°Π³ΡΡΠ·ΠΊΠΎΠΉ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΌΠ½ΠΎΠ³ΠΎΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ Π‘Π‘ΠΠ‘, ΠΊΠΎΡΠΎΡΠ°Ρ ΠΏΠΎΠ²ΡΡΠ°Π΅Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π‘ΠΠΠ Π² Π·Π°Π΄Π°ΡΠ°Ρ
ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΠΎΡΡΠΎΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ° ΠΏΡΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°Π»ΡΠ½ΡΡ
Π²Π°ΡΠΈΠ°Π½ΡΠ°Ρ
ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ.ΠΡΠ²ΠΎΠ΄Ρ. ΠΡΡ
Π°Π½ΠΈΠ΅ Ρ ΡΠΈΠΊΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠ°ΡΡΠΎΡΠΎΠΉ Π½ΠΎΡΠΌΠ°Π»ΠΈΠ·ΡΠ΅Ρ ΡΠ΅Π³ΡΠ»ΡΡΠΈΡ Π‘Π‘ΠΠ‘, ΠΊΠ°ΠΊ Ρ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
, ΡΠ°ΠΊ ΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ. ΠΡΠΈ ΡΠΌΠ΅ΡΠ΅Π½Π½ΠΎΠΉ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π½Π°Π³ΡΡΠ·ΠΊΠ΅ (ΠΌΠ΅Π½Π΅Π΅ 80 ΠΡ) ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π‘Π‘ΠΠ‘ Ρ ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΠΈΠ·ΠΌΠ΅Π½ΡΡΡΡΡ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠΎΠΉ, ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ Π·Π° ΡΡΠ΅Ρ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΡΠΌΠ° ΠΈ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ. ΠΡΠΈ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ ΠΏΡΠΎΠ±Ρ Ρ ΡΠΌΠ΅ΡΠ΅Π½Π½ΠΎΠΉ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π½Π°Π³ΡΡΠ·ΠΊΠΎΠΉ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π‘Π‘ΠΠ‘ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ°Π·Π»ΠΈΡΠ°Π΅ΡΡΡ ΠΏΠΎ ΡΠ΄Π°ΡΠ½ΠΎΠΌΡ ΠΎΠ±ΡΠ΅ΠΌΡ (Π£Π): Π² Π³ΡΡΠΏΠΏΠ΅ Ρ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΠΌΠΈ Π½Π°ΡΡΡΠ΅Π½ΠΈΡΠΌΠΈ Π·Π½Π°ΡΠ΅Π½ΠΈΡ Π£Π Π±ΡΠ»ΠΈ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ Π½ΠΈΠΆΠ΅, ΡΠ΅ΠΌ Π² Π³ΡΡΠΏΠΏΠ΅ Π±Π΅Π· ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΡ
Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ.
- β¦